Search details
1.
Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
Cancer
; 130(11): 2031-2041, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38294959
2.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Lancet Oncol
; 24(9): 1002-1017, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37657460
3.
A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer.
Oncologist
; 28(7): 644-e564, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37186063
4.
Neoadjuvant Gene-Mediated Cytotoxic Immunotherapy for Non-Small-Cell Lung Cancer: Safety and Immunologic Activity.
Mol Ther
; 29(2): 658-670, 2021 02 03.
Article
in English
| MEDLINE | ID: mdl-33160076
5.
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology
; 99(9): 580-588, 2021.
Article
in English
| MEDLINE | ID: mdl-33957633
6.
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.
BMC Cancer
; 21(1): 1094, 2021 Oct 11.
Article
in English
| MEDLINE | ID: mdl-34635061
7.
Patient-reported outcomes with durvalumab by PD-L1 expression and prior chemoradiotherapy-related variables in unresectable stage III non-small-cell lung cancer.
Future Oncol
; 17(10): 1165-1184, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33583206
8.
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
Cancer
; 126(22): 4867-4877, 2020 11 15.
Article
in English
| MEDLINE | ID: mdl-32914866
9.
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
Cancer
; 125(3): 406-415, 2019 02 01.
Article
in English
| MEDLINE | ID: mdl-30341983
10.
Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.
J Natl Compr Canc Netw
; 17(5): 469-477, 2019 05 01.
Article
in English
| MEDLINE | ID: mdl-31085759
11.
A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: Efficacy, safety, and adherence.
Psychooncology
; 28(3): 561-569, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30680852
12.
Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA).
Future Oncol
; 15(24): 2841-2855, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-31364872
13.
Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.
Mol Ther
; 26(5): 1198-1205, 2018 05 02.
Article
in English
| MEDLINE | ID: mdl-29550074
14.
Tumor Treating Fields therapy in metastatic non-small-cell lung cancer - Authors' reply.
Lancet Oncol
; 24(12): e454, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38039996
15.
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.
Oncologist
; 23(8): 891-899, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29650685
16.
Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Cancer
; 123(21): 4244-4251, 2017 Nov 01.
Article
in English
| MEDLINE | ID: mdl-28678434
17.
The use of varenicline to treat nicotine dependence among patients with cancer.
Psychooncology
; 26(10): 1526-1534, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-27218657
18.
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.
Lancet Oncol
; 17(12): 1683-1696, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27836716
19.
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.
Lancet Oncol
; 17(11): 1497-1508, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27745820
20.
Capecitabine and lapatinib for the first-line treatment of metastatic/recurrent head and neck squamous cell carcinoma.
Cancer
; 122(15): 2350-5, 2016 08 01.
Article
in English
| MEDLINE | ID: mdl-27197056